Eli Lilly is studying two weight loss candidates in phase 3 trials ... A small player like Viking may also win by attracting ...

A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

Eli Lilly's weight loss drug sales in Q3 weren't as strong as ... More importantly, investors need to recognize that the most ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Shares of Nvidia surged to a record high on Thursday, marking a historic milestone as the chipmaker became the first company ...

The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...

CENTRAL GOVERNMENT FUNDS: Social welfare would account for the largest portion of the NT$3.33 trillion budget, followed by spending on education, tech and culture ...

iOn a rolling basis, stocks which come in top 80% of total market-cap are considered largecaps, next 15% midcaps and remaining 5% smallcaps. (Total m-cap classification is done on a daily basis).